Ruxience 00069-0249

Generic: Rituximab-Pvvr

Product NDC

00069-0249

Manufacturer: Pfizer Laboratories Div Pfizer Inc
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: January 23, 2020
Listing Expires: December 31, 2027
Application: BLA761103

Need to source Ruxience? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Rituximab	500 mg/50mL

Drug Class

CD20-directed Cytolytic Antibody [EPC]CD20-directed Antibody Interactions [MoA]CD20-directed Cytolytic Antibody [EPC]

Packaging Options(1)

00069-0249-01

1 VIAL, SINGLE-USE in 1 CARTON (0069-0249-01) / 50 mL in 1 VIAL, SINGLE-USE

View →